FDA Approval Summary: Pertuzumab, Trastuzumab, and...

Clinical Cancer Research 2020 / 11

FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf injection for subcutaneous use in Patients with HER2-Positive Breast Cancer

Gao, Jennifer J, Osgood, Christy L., Gong, Yutao, Zhang, Hui, Bloomquist, Erik W, Jiang, Xiling, Qiu, Junshan, Yu, Jingyu, Song, Pengfei, Rahman, Atiqur, Chiu, Haw-Jyh, Ricks, Tiffany K., Rizvi, Fatim
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-20-3474
Date:
November, 2020
File:
PDF, 328 KB
2020
Conversion to is in progress
Conversion to is failed